CVS Health (CVS) Misses Q1 EPS by 38c; Lowers Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to CVS Health (CVS) Misses Q1 EPS by 38c; Lowers Outlook
May 2, 2024 5:38 AM EDT
BofA Securities analyst Michael Cherny lowered the price target on CVS Health (NYSE: CVS) to $77.00 (from $95.00) while maintaining a Buy rating.
The analyst comments "Shares of CVS currently trade at 8x earnings, implying investors have substantial doubt the company can... More
May 1, 2024 6:55 AM EDT
(Updated - May 1, 2024 11:42 AM EDT)
CVS Health (NYSE: CVS) reported a decline in first-quarter profits and slashed its full-year earnings outlook, sending shares down more than 17% Wednesday as both earnings and revenue fell short of Wall Street expectations. The healthcare giant posted adjusted earnings per share (EPS) of $1.33 for the quarter, which was significantly below the analyst consensus of $1.71. Revenue for the quarter was $88.4 billion, also missing the consensus estimate of $89.33 billion.
The company's first-quarter revenue saw a 3.7% increase compared to the same period last year, driven by growth in the Health Care... More
